文献速递乳腺癌放疗放疗物理与技术

乳腺癌质子放疗患者整体纵向应变的连续测量:一项70例患者的前瞻性试验

Serial Measurement of Global Longitudinal Strain Among Women With Breast Cancer Treated With Proton Radiation Therapy: A Prospective Trial for 70 Patients.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2022-08-24

这项前瞻性、观察性、单中心研究纳入70例接受质子放疗的乳腺癌女性,在放疗前、放疗结束后4周及结束后2个月连续测量整体纵向应变、高敏肌钙蛋白I和NT-proBNP。结果显示质子放疗未影响左心室射血分数、整体或节段整体纵向应变及生物标志物,但事后亚组分析中高血压女性整体纵向应变下降更明显。

要点

  • 质子放疗后左心室射血分数、整体纵向应变及生物标志物均无显著变化。
  • 事后亚组分析显示高血压女性整体纵向应变下降幅度大于无高血压女性。
  • 数据支持质子放疗相较常规光子放疗可能具有心脏获益。

核心结论

  • 质子放疗未影响左心室功能,且未伴随生物标志物升高。
  • 这些数据支持质子放疗相较常规放疗可能具有心脏获益。

研究设计与样本

  • 前瞻性、观察性、单中心研究,纳入70例接受质子放疗的乳腺癌女性。
  • 在预设时间点(质子放疗前、放疗结束后4周、放疗结束后2个月)连续测量整体纵向应变、高敏肌钙蛋白I和NT-proBNP。

主要发现

  • 患者平均年龄46±11岁,平均体重指数25.6±5.2 kg/m2,32%患者有高血压,心脏和左心室平均放疗剂量分别为0.44 Gy和0.12 Gy。
  • 左心室射血分数从放疗前到放疗后无变化(65±5 vs 66±5 vs 64±4%;P=.15)。
  • 整体整体纵向应变从放疗前到放疗后无变化(-21.7±2.7 vs -22.7±2.3 vs -22.8±2.1%;P=.24),节段整体纵向应变亦无变化。
  • 高敏肌钙蛋白和NT-proBNP在质子放疗后均无变化。
  • 事后亚组分析中,高血压女性质子放疗后整体纵向应变下降幅度大于无高血压女性(-21.3±3.5 vs -24.0±2.4%;P=.006)。

局限性

  • 事后亚组分析显示高血压女性整体纵向应变下降更明显,该结果为事后分析。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Conventional photon radiation therapy (RT) for breast cancer is associated with a reduction in global longitudinal strain (GLS) and an increase in troponin, N-terminal pro hormone B-type natriuretic peptide (NT-proBNP), and incident heart failure. The cardiac radiation exposure with proton-RT is much reduced and thus may be associated with less cardiotoxicity. The objective was to test the effect of proton-RT on GLS, troponin, and NT-proBNP. METHODS AND MATERIALS: We conducted a prospective, observational, single-center study of 70 women being treated with proton-RT for breast cancer. Serial measurements of GLS, high-sensitivity troponin I, and NT-proBNP were performed at prespecified intervals (before proton-RT, 4 weeks after completion of proton-RT, and again at 2 months after proton-RT). RESULTS: The mean age of the patients was 46 ± 11 years, and the mean body mass index was 25.6 ± 5.2 kg/m2; 32% of patients had hypertension, and the mean radiation doses to the heart and the left ventricle (LV) were 0.44 Gy and 0.12 Gy, respectively. There was no change in left ventricular ejection fraction (65 ± 5 vs 66 ± 5 vs 64 ± 4%; P = .15), global GLS (-21.7 ± 2.7 vs -22.7 ± 2.3 vs -22.8 ± 2.1%; P = .24), or segmental GLS from before to after proton-RT. Similarly, there was no change in either high-sensitivity troponin or NT-proBNP with proton-RT. However, in a post hoc subset analysis, women with hypertension had a greater decrease in GLS after proton-RT compared with women without hypertension (-21.3 ± 3.5 vs -24.0 ± 2.4%; P = .006). CONCLUSIONS: Proton-RT did not affect LV function and was not associated with an increase in biomarkers. These data support the potential cardiac benefits of proton-RT compared with conventional RT.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Hassan MZO, Awadalla M, Tan TC, et al. Serial Measurement of Global Longitudinal Strain Among Women With Breast Cancer Treated With Proton Radiation Therapy: A Prospective Trial for 70 Patients. Int J Radiat Oncol Biol Phys. 2022. PMID: 36028065. doi:10.1016/j.ijrobp.2022.08.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。